Total Payments
$8,812
2024 Payments
$2,048
Companies
46
Transactions
303
Medicare Patients
5,222
Medicare Billing
$406,163
Payment Breakdown by Category
Food & Beverage$8,642 (98.1%)
Education$169.39 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,642 | 285 | 98.1% |
| Education | $169.39 | 18 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,284 | 38 | $0 (2024) |
| Amarin Pharma Inc. | $1,094 | 31 | $0 (2022) |
| Amgen Inc. | $667.24 | 23 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $629.37 | 22 | $0 (2024) |
| Gilead Sciences, Inc. | $539.82 | 18 | $0 (2022) |
| Merck Sharp & Dohme LLC | $532.68 | 29 | $0 (2024) |
| Novo Nordisk Inc | $510.47 | 27 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $474.17 | 14 | $0 (2018) |
| Intra-Sana Laboratories | $271.83 | 6 | $0 (2024) |
| PFIZER INC. | $256.09 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,048 | 50 | AstraZeneca Pharmaceuticals LP ($693.93) |
| 2023 | $1,181 | 31 | Amgen Inc. ($462.24) |
| 2022 | $424.77 | 29 | Lilly USA, LLC ($72.56) |
| 2021 | $602.90 | 34 | Biohaven Pharmaceuticals, Inc. ($147.81) |
| 2020 | $657.28 | 26 | Gilead Sciences, Inc. ($304.42) |
| 2019 | $993.44 | 48 | Amarin Pharma Inc. ($330.31) |
| 2018 | $389.70 | 22 | AstraZeneca Pharmaceuticals LP ($114.47) |
| 2017 | $2,515 | 63 | Amarin Pharma Inc. ($682.29) |
All Payment Transactions
303 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.16 | General |
| 12/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $127.82 | General |
| 12/11/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $17.07 | General |
| 12/04/2024 | RGH Enterprises LLC | — | Food and Beverage | In-kind items and services | $29.31 | General |
| 12/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $8.83 | General |
| Category: VACCINES | ||||||
| 11/07/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $127.69 | General |
| Category: GALLSTONES | ||||||
| 11/07/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: GALLSTONES | ||||||
| 10/31/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Inflammation | ||||||
| 10/23/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $121.85 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $122.06 | General |
| Category: VACCINES | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 09/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $123.00 | General |
| Category: Obesity | ||||||
| 07/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.17 | General |
| 07/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: Oncology | ||||||
| 07/18/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: VACCINE | ||||||
| 07/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,286 | 2,028 | $246,295 | $112,416 |
| 2022 | 14 | 1,370 | 2,457 | $257,060 | $122,460 |
| 2021 | 14 | 1,335 | 2,237 | $232,390 | $94,591 |
| 2020 | 12 | 1,231 | 1,902 | $197,855 | $76,697 |
Total Patients
5,222
Total Services
8,624
Medicare Billing
$406,163
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 215 | 577 | $100,975 | $41,282 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 153 | 276 | $62,100 | $27,919 | 45.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 134 | 134 | $26,800 | $19,055 | 71.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 115 | 124 | $12,400 | $9,378 | 75.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 115 | 125 | $5,000 | $4,246 | 84.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 12 | $4,800 | $2,932 | 61.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 13 | $4,550 | $2,169 | 47.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 154 | 218 | $3,270 | $1,831 | 56.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 119 | 133 | $13,300 | $1,427 | 10.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 182 | 286 | $8,560 | $975.26 | 11.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 32 | 63 | $2,520 | $753.88 | 29.9% |
| 90471 | Administration of vaccine | Office | 2023 | 23 | 23 | $920.00 | $396.51 | 43.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 20 | 44 | $1,100 | $51.28 | 4.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 222 | 556 | $97,300 | $41,441 | 42.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 175 | 307 | $69,075 | $32,702 | 47.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 61 | 381 | $19,050 | $14,460 | 75.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 90 | 90 | $18,000 | $13,174 | 73.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 122 | 124 | $12,400 | $8,700 | 70.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 113 | 117 | $4,680 | $3,944 | 84.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 16 | $3,900 | $2,442 | 62.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 102 | 109 | $10,900 | $1,282 | 11.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 37 | 88 | $3,520 | $1,118 | 31.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 193 | 304 | $9,110 | $1,045 | 11.5% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 13 | 21 | $2,520 | $856.83 | 34.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 172 | 246 | $3,690 | $728.82 | 19.8% |
About Dr. Vishal Patel, MD
Dr. Vishal Patel, MD is a Family Medicine healthcare provider based in Northvale, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093781957.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vishal Patel, MD has received a total of $8,812 in payments from pharmaceutical and medical device companies, with $2,048 received in 2024. These payments were reported across 303 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($8,642).
As a Medicare-enrolled provider, Patel has provided services to 5,222 Medicare beneficiaries, totaling 8,624 services with total Medicare billing of $406,163. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Northvale, NJ
- Active Since 02/28/2006
- Last Updated 06/22/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1093781957
Products in Payments
- Vascepa (Drug) $1,094
- JARDIANCE (Drug) $731.73
- FARXIGA (Drug) $669.91
- Otezla (Drug) $330.25
- BREZTRI (Drug) $306.91
- RELTONE 200 MG (Drug) $271.83
- Repatha (Biological) $247.22
- JANUVIA (Drug) $242.23
- INVOKANA (Drug) $240.40
- Descovy (Drug) $236.10
- XARELTO (Drug) $227.75
- VOQUEZNA (Drug) $197.01
- CONTRAVE (Drug) $179.47
- Ozempic (Drug) $178.74
- NURTEC ODT (Drug) $162.11
- INJECTAFER (Drug) $153.88
- AIRSUPRA (Drug) $139.76
- Livalo (Drug) $133.68
- DALVANCE (Drug) $130.00
- AREXVY (Drug) $125.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.